(Q42758470)

6 November 2017

Pharmacokinetics and tolerability of lamotrigine and olanzapine coadministered to healthy subjects (English)

1 reference

6 November 2017

1 reference

1 reference

Jagdev Sidhu

1

1 reference

6 November 2017

Sarah Job

2

1 reference

6 November 2017

Jonathan Bullman

3

1 reference

6 November 2017

Emma Francis

4

1 reference

6 November 2017

Richard Abbott

5

1 reference

6 November 2017

John Ascher

6

1 reference

6 November 2017

Jochen G W Theis

7

1 reference

6 November 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

British Journal of Clinical Pharmacology

6 November 2017

1 reference

6 November 2017

61

1 reference

6 November 2017

4

1 reference

6 November 2017

420-426

1 reference

A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.

6 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885046

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885046

Clinical pharmacodynamics and pharmacokinetics of antimanic and mood-stabilizing medications

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885046

An ever-increasing pharmacopoeia for the management of patients with bipolar disorder.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885046

Mood stabilizer combinations: a review of safety and efficacy

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885046

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885046

Pharmacokinetics and safety of lamotrigine (Lamictal) in patients with epilepsy

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885046

A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885046

Olanzapine versus placebo in acute mania: treatment responses in subgroups

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885046

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885046

Glucuronidation of olanzapine by cDNA-expressed human UDP-glucuronosyltransferases and human liver microsomes

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885046

The assessment of individual and population bioequivalence.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885046

Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885046

In vitro N-glucuronidation of a novel antiepileptic drug, lamotrigine, by human liver microsomes

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16542203

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Disposition and biotransformation of the antipsychotic agent olanzapine in humans

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16542203

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.2006.02598.X

1 reference

6 November 2017

1 reference

6 November 2017

PubMed publication ID

16542203

1 reference